The need to disclose the composition of medical devices at the European level
Contact Dermatitis
.
2019 Sep;81(3):159-160.
doi: 10.1111/cod.13354.
Authors
Anne Herman
1
2
,
An Goossens
3
Affiliations
1
Department of Dermatology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
2
Institute of Experimental and Clinical Research, Pneumology, ENT and Dermatology Pole, Université catholique de Louvain, Brussels, Belgium.
3
Department of Dermatology, University Hospitals, KU Leuven, Leuven, Belgium.
PMID:
31309587
DOI:
10.1111/cod.13354
No abstract available
Publication types
Editorial
MeSH terms
Dermatitis, Allergic Contact / etiology*
Disclosure / legislation & jurisprudence*
Equipment and Supplies / adverse effects*
European Union
Humans
Manufacturing Industry / legislation & jurisprudence*